Cargando…

Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy

B cells lymphoma is one of the most challenging extra-hepatic manifestations of hepatitis C virus (HCV). Recently, a new kind of B-cell lymphoma, named double-hit B (DHL), was characterized with an aggressive clinical course whereas a potential association with HCV was not investigated. The new anti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galati, Giovanni, Rampa, Lorenzo, Vespasiani-Gentilucci, Umberto, Marino, Mirella, Pisani, Francesco, Cota, Carlo, Guidi, Alessandro, Picardi, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067444/ https://www.ncbi.nlm.nih.gov/pubmed/27803769 http://dx.doi.org/10.4254/wjh.v8.i29.1244

Ejemplares similares

The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2016)

Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2013)

Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination
por: Galati, Giovanni, et al.
Publicado: (2014)

Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study
por: De Vincentis, Antonio, et al.
Publicado: (2016)

Exhaled breath analysis in hepatology: State-of-the-art and perspectives
por: De Vincentis, Antonio, et al.
Publicado: (2019)

Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD)
por: Galati, Giovanni, et al.
Publicado: (2014)

The Liver as Another Possible Target Organ for Bacillus cereus Infection
por: Alessandri-Bonetti, Mario, et al.
Publicado: (2016)

Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures
por: Gallo, Paolo, et al.
Publicado: (2022)

Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2018)

Boosting pigment epithelial-derived factor: a promising approach for the treatment of early portal hypertension
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2015)

Steroid-refractory immune related hepatitis may hide viral re-activation
por: Citarella, Fabrizio, et al.
Publicado: (2020)

Advancing the management of double hit lymphoma
por: Landsburg, Daniel J.
Publicado: (2017)

Drug therapy for double-hit lymphoma
por: Phuoc, Vania, et al.
Publicado: (2019)

Tolosa-Hunt Syndrome in Double-Hit Lymphoma
por: Peddi, Prakash, et al.
Publicado: (2015)

Rational targeted therapeutics for double-hit lymphoma
por: Azizian, Nancy G, et al.
Publicado: (2019)

Double hit mouse model of Parkinson's disease
por: Schirinzi, Tommaso, et al.
Publicado: (2016)

Altered pathways and targeted therapy in double hit lymphoma
por: Zhuang, Yuxin, et al.
Publicado: (2022)

Flow Cytometric Evaluation of Double/Triple Hit Lymphoma
por: Roth, Christine G., et al.
Publicado: (2016)

Inborn and acquired risk factors for severe liver disease in Europeans with type 2 diabetes from the UK Biobank
por: Tavaglione, Federica, et al.
Publicado: (2021)

Lysosomal Acid Lipase Activity Is Reduced Both in Cryptogenic Cirrhosis and in Cirrhosis of Known Etiology
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2016)

Double-hit lymphoma of the male breast: a case report
por: Elgaafary, Shaymaa, et al.
Publicado: (2020)

Diagnostic Approach for Double-Hit and Triple-Hit Lymphoma Based on Immunophenotypic and Cytogenetic Characteristics of Bone Marrow Specimens
por: Kim, Heyjin, et al.
Publicado: (2020)

Voltammetric analysis for distinguishing portal hypertension-related from malignancy-related ascites: A proof of concept study
por: Muley, Moises, et al.
Publicado: (2020)

Peripheral immune cell profiling of double-hit lymphoma by mass cytometry
por: Lei, Tao, et al.
Publicado: (2023)

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
por: Pellicelli, Adriano M, et al.
Publicado: (2012)

Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank
por: De Vincentis, Antonio, et al.
Publicado: (2021)

Clinical Significance of “Double-hit” and “Double-protein” expression in Primary Gastric B-cell Lymphomas
por: He, Miaoxia, et al.
Publicado: (2016)

Ataxia's double hit
por: Leslie, Mitch
Publicado: (2010)

Dose-adjusted EPOCH and rituximab for the treatment of double expressor and double-hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome
por: Dodero, Anna, et al.
Publicado: (2021)

SUN-564 ATG7 Overexpression Results in Reduction of Hepatocellular Lipid Content in Vitro
por: Tavaglione, Federica, et al.
Publicado: (2020)

Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2018)

Reelin Expression in Human Liver of Patients with Chronic Hepatitis C Infection
por: Carotti, Simone, et al.
Publicado: (2017)

Cutaneous presentation of Double Hit Lymphoma: A Case Report With Review of the Literature
por: Khelfa, Yousef, et al.
Publicado: (2016)

Pharmacological targeting PIKfyve and tubulin as an effective treatment strategy for double-hit lymphoma
por: Feng, Liying, et al.
Publicado: (2022)

Clinical Features and Immunophenotypes of Double-Hit Diffuse Large B-Cell Lymphoma
por: Wu, Cheng-Han, et al.
Publicado: (2022)

Targeting MYC and BCL2 by a natural compound for “double‐hit” lymphoma
por: Liu, Xiaoqian, et al.
Publicado: (2022)

Transformation of double-hit follicular lymphoma to plasmablastic lymphoma: a partial role of MYC gene rearrangement
por: Ise, Mikiko, et al.
Publicado: (2018)

Assessment of CD52 expression in "double-hit" and "double-expressor" lymphomas: Implications for clinical trial eligibility
por: Craig, Jeffrey W., et al.
Publicado: (2018)

Unusual presentation of extra-nodal double-hit follicular lymphoma: a case report
por: Lazzi, Stefano, et al.
Publicado: (2022)

P1674: CLINICAL IMPACT OF NON-ADHERENCE TO HIT GUIDELINES: A DOUBLE HIT IN HIT
por: Al Raizah, A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p4nv38mj9o7eq66uldilu32g0k